Xencor | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.52B 1.73B 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.38B 675.8M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Cytokinetics USD 94.86M 47.97M 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
J&J USD 38.47B 32.35B 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 13.24B 1.35B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.04B 49M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Xencor USD 40.88M 11.84M 2024-12



Xencor Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.